STAT+: 3 burning questions about the future of prescribing drugs online
Online companies prescribing and dispensing medications like Adderall are garnering increasing scrutiny from clinicians and…
Category: Pharmaceuticals
STAT+: National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program
In a notable bid to widen global access to Covid-19 medical products, the National Institutes…
STAT+: Roche anti-TIGIT cancer immunotherapy fails second clinical trial
Roche said Wednesday that its experimental cancer immunotherapy directed against a target called TIGIT suffered…
STAT+: Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic
After 18 months, the fate of a contentious proposal before the World Trade Organization to…
Pharma showers John Thune with campaign cash
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Opinion: Flawed FDA safety requirements are hamstringing a highly effective treatment for severe schizophrenia
For medications with serious safety concerns the Food and Drug Administration mandates a Risk Evaluation…
A clash over online Adderall prescriptions is raising new questions about telehealth
Online pharmacy startups have pledged to make it faster and easier than ever to get…
STAT+: California fines an OptumRx pharmacy for jeopardizing patient health. Is that enough?
The California Board of Pharmacy fined OptumRx, one of the largest pharmacy benefit managers in…
STAT+: With new diabetes drug data, Eli Lilly is taking aim at obesity
Eli Lilly released new data Thursday showing that an injectable diabetes drug it is developing,…
Biden administration starts Covid treatment push, focusing on Pfizer’s Paxlovid
The Biden administration announced a series of initiatives Tuesday aimed at increasing the use of…
STAT+: U.S. spending on pharmaceuticals jumped 12% in 2021, fueled by costs of Covid-19 vaccines and therapies
Thanks to Covid-19 vaccines and therapies, U.S. spending on pharmaceuticals rose 12% in 2021 as…
Opinion: STAT+: Pharma’s role in value-based care starts with value-based research
Modern medicine has been sculpted by the ever-expanding knowledge of biological processes in conjunction with…
.jpg)
Opinion: Will the shadow of Aduhelm cloud FDA’s decision-making on an ALS therapy?
On March 30, an FDA advisory panel voted 6 to 4 against recommending approval of…
STAT+: Endo wins a reprieve in an opioid lawsuit in Tennessee as appeals court overturns sanctions
Endo International won a key battle over its role in the opioid crisis in Tennessee…
STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs
After three years of squabbling, Bristol Myers Squibb has agreed to pay up to $11…
STAT+: Halozyme to acquire Antares for nearly $1B in bid to dominate drug delivery market
San Diego biotech Halozyme announced Wednesday that it plans to buy drug development and delivery…
STAT+: Good fortunes continue for Sierra Oncology with $1.9 billion acquisition by U.K. pharma giant Glaxo
Sierra Oncology is having a very good year. On Wednesday, the small U.S. drugmaker said…
STAT+: Pharma pledges faster drug launches in Europe in hopes of avoiding stricter regulations
In a bid to thwart stricter regulation, the European pharmaceutical industry trade group pledged to…
STAT+: FDA scolds Bausch Health for misleading claims about a psoriasis cream
The U.S. Food and Drug Administration has scolded Bausch Health for a video and webpage…
STAT+: Wyden wants details on Merck’s U.S. taxes as part of expanding probe into pharma practices
The head of the U.S. Senate Finance Committee is seeking details from Merck about the…
STAT+: Pharma companies face shareholder proposals to widen access to medicines, rework business plans
Over the next few weeks, several major pharmaceutical companies will face a fresh crop of…
STAT+: Roche anti-TIGIT cancer immunotherapy fails in first late-stage clinical trial
Roche said Wednesday that an experimental cancer immunotherapy directed against a target called TIGIT failed…
STAT+: Inflation caused ‘unprecedented’ drops in net pharmaceutical prices, analysis finds
Amid ongoing turmoil over the cost of prescription medicines, a new analysis finds that brand-name…
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
U.S. health officials on Friday stopped the further deployment of the Covid-19 treatment sotrovimab to…
STAT+: Despite competition, U.S. cancer drug prices rose even as they fell in Germany and Switzerland
Even as prices rose substantially in the U.S. over a recent 12-year period, a new…
STAT+: Sun Pharmaceuticals to pay $485 million to settle claims its Ranbaxy unit caused customers to overpay for generics
On the eve of a trial, Sun Pharmaceuticals has agreed to pay $485 million to…
STAT+: Pfizer inks deal with UNICEF to supply Covid pill to poor countries, but advocates say it isn’t enough
As part of an effort to widen access to its Covid-19 pill, Pfizer has reached…
STAT+: When should drugmakers go all in and cut off essential medicines to Russia?
Just say nyet? As the war in Ukraine intensifies, several of the world’s largest pharmaceutical…
Opinion: If pharma can market to youths by TikTok, it should include them in clinical trials
The pharmaceutical industry has rapidly adapted to promoting prescription drugs to young people on TikTok,…
STAT+: Watcdog says Lilly made ‘false assertions’ about impact of pausing political donations after Jan. 6 attack
Early last year, Eli Lilly (LLY) temporarily halted contributions made to members of Congress who…
STAT+: Combination treatment from Nektar and Bristol Myers Squibb fails to benefit patients with melanoma, study shows
Nektar Therapeutics said Monday that its experimental immunotherapy failed to provide additional benefit for patients…
STAT+: Pharmalittle: Insurers balk at opioid payouts to drugmakers and wholesalers; AbbVie settles another Humira biosimilar lawsuit
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: An international treaty is needed to prevent countries from banning exports of medical products, experts urge
Amid increasing concern over shortages of medical products, a new study recommends that the United…
STAT+: Washington state moves closer to creating the next prescription drug affordability board
In a closely watched development, House lawmakers in Washington state passed a bill to create…
Opinion: Inappropriate march-in actions would jeopardize public-private partnerships that make lifesaving medicines possible
For decades, partnerships among government-funded academic institutions and private companies in the United States have…
Opinion: Turning to social media to get affordable insulin: a clear sign of a broken health care system
I am part of an underground market for drugs that looks a lot different from…
STAT+: Awaiting ‘definitive’ Alzheimer’s drug data, Roche and Genentech launch ambitious new study
Partners Roche and Genentech are studying whether their investigational treatment for Alzheimer’s disease can prevent…
STAT+: Supreme Court debates exactly when a doctors’ misprescribing becomes criminal
Supreme Court justices on Tuesday seemed divided over where to draw the line for what…
STAT+: Tennessee judge sanctions Endo for ‘coordinated strategy’ to withhold documents in opioid case
Endo International (ENDP) was sanctioned by a Tennessee state court judge for using a “coordinated…
Opinion: The future of pharma and health care will come in small (molecule) packages
Rightful accolades to Moderna and Pfizer/BioNTech for the Covid-19 vaccines they created and developed in…
STAT+: Oregon withdraws a waiver request to run a closed Medicaid formulary
In response to a raft of concerns, Oregon has withdrawn a request made to federal…
STAT+: Ants, spiders, and mold: Why a big compounding pharmacy recently recalled all its products
Last December, a little known compounding pharmacy recalled all of its products due to “process…
STAT+: NIH official accused of ‘bias’ against using a controversial law to address high drug prices
The campaign to use so-called march-in rights to widen access to a cancer drug is…
STAT+: Judge bars Shkreli from running another public company, fines him $1.4 million
A U.S. District Court judge has granted a request from the U.S. Securities and Exchange…
STAT+: Drug makers ring in the new year with 5% price hikes on hundreds of medicines
As 2022 gets under way, pharmaceutical companies have so far raised wholesale prices by a…
STAT+: The biotech scorecard for the first quarter: 19 stock-moving events to watch
Happy New Year! Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events,…
STAT/Harris Poll: Vaccinated Americans far more likely to take Pfizer Covid-19 pill than unvaccinated people
Just before regulators authorized use of a widely publicized Covid-19 pill from Pfizer, only half…
STAT+: Pharmalittle: Japan panel nixes Biogen Alzheimer’s drug; Oxfam urges SEC to probe Moderna over patent dispute remarks
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: Moderna says booster shot raises antibody levels to thwart Omicron; Sanofi buys yet another biotech
Rise and shine, everyone, another busy day is on the way. Although it may feel…
STAT+: AbbVie asks the U.S. International Trade Commission to investigate Alvotech’s plans for a biosimilar Humira
In its latest bid to defend its franchise product, AbbVie (ABBV) has filed a complaint…